People in the News

Jan 13, 2015

Patrick Carpenter

Vermillion said today that it has appointed Patrick Carpenter general manager of its CLIA laboratory business, Aspira Labs. Carpenter was previously vice president of operations at Miraca Life Sciences. Before that, he held positions at companies including Dianon Systems, VCA/Antech Diagnostics, and Quest Diagnostics.

Jan 12, 2015

Laura Miller

Vermillion said today that it has appointed Laura Miller senior vice president of sales/customer experience. Miller was previously an independent healthcare consultant. Before that, she was president, laboratory services, for HealthTronics Laboratory. She has also held senior leadership roles at PLUS Diagnostics, Dianon Systems, US Labs, and Ventana Medical Systems.

Jan 12, 2015

Merilee Raines

Merilee Raines has joined Affymetrix's board of directors and will serve as a member of the audit committee. Raines served as CFO of Idexx Laboratories from 2003 until her retirement in 2013. Prior to this, she held various management positions at Idexx, including vice president of finance, treasurer, director of finance, and controller.

Jan 09, 2015

Marylyn Ritchie

Marylyn Ritchie has been appointed senior investigator and founding director of Geisinger's newly established Biomedical and Translational Informatics program. Ritchie will maintain her laboratory at Pennsylvania State University where she is also a professor in the department of biochemistry and molecular biology. She is also the director of the school's Center for Systems Genomics. 

As part of her duties at Geisinger, she will recruit faculty members with expertise in health informatics and bioinformatics for the new program 

Jan 09, 2015

Jennifer Skeen, Sue Beruti

BioTheranostics announced Jennifer Skeen has joined the firm as VP of clinical operations, while Sue Beruti joined the company as medical director. 

Skeen has 10 years of clinical laboratory operations management experience and was previously at Pathway Genomics, Asuragen, and Alvern Clinical Laboratories. Beruti was most recently director of pathology and medical affairs at Genoptix, where she headed the Biopharma Medical Division and medical affairs group. 

Jan 09, 2015

Scott Coward

Scott Coward was named by Exact Sciences as its senior vice president and general counsel, effective Jan. 1. Coward was most recently managing partner of K&L Gates' Raleigh, NC office, where he specialized in corporate and securities law, and M&A for life science companies. Prior to that, he was general counsel at Blue Rhino, associate general counsel at GE Medical Systems Information Technologies, and a partner at Smith Anderson. 

Jan 08, 2015

Bernhard Kirschbaum

Protagen said that Bernhard Kirschbaum has joined the firm's supervisory board. Kirschbaum is the former head of research and early development of Merck Serono and has held executive positions at Hoechst, Aventis, Sanofi, and Merck Serono. 

Jan 08, 2015

Douglas Sanders

Integrated Diagnostics has appointed Douglas Sanders as its CFO. Most recently, Sanders was CFO of CMC Biologics. Prior to that, he spent 15 years at Hoffmann-La Roche, most recently as head of business operations and CFO for Roche Consumer Health. He was also CFO of MediQuest Therapeutics. 

Jan 06, 2015

David Mitchell

The board of the Australian Centre for Plant Functional Genomics has appointed David Mitchell its CEO, effective Jan. 19. Mitchell has extensive experience leading and developing cross-disciplinary teams in the public as well as the private sectors. He was at the Commonwealth Scientific and Industrial Research Organisation for seven years and played a leadership role in developing CSIRO's bioinformatics capabilities and he held roles that were responsible for performing due diligence on commercial transactions and identifying business opportunities for spin-outs.

Jan 06, 2015

Sudipto Sur

Signal Genetics has appointed Sudipto Sur as the company's chief information officer. Sur will report directly to Signal President and CEO Samuel Riccitelli. He will be responsible for the company's initiatives in informatics, healthdare data analysis, and translating business metrics into actionable corporate strategy and has more than 14 years of experience in business and technology development strategy and data analysis.

Most recently, Sur was president of Anssur and was founder and CEO of Miralex Systems. Previously, he was director of R&D for informatics and systems for Sequenom, and before that he served as associate director for control systems and software for Genoptix. He also has held positions at Able and OMM. 

Jan 06, 2015

Carl Feldbaum

Trovagene has appointed Carl Feldbaum to its board. He will chair the company's corporate governance and nominating committee. From 1993 to 2005, Feldbaum was president of the Biotechnology Industry Organization, and he currently is on the boards of Actelion Pharmaceuticals and Exelixis. He also serves as director of BIO Ventures for Global Health, and The Life Sciences Foundation. He previously served as chief of staff to Sen. Arlen Specter of Pennsylvania. 

Jan 06, 2015

David Mittelman

Tute Genomics has hired David Mittelman as its chief scientific officer. He joins the company from Arpeggi, a bioinformatics company he co-founded that was acquired by Gene by Gene in 2013. Previously he was an associate professor at Virginia Tech. Mittelman has a PhD in molecular biophysics from Baylor College of Medicine and completed his postdoctoral training at Baylor’s Human Genome Sequencing Center.

Jan 06, 2015

Rob Brown

Rob Brown has joined Dotmatics in the newly created position of vice president of global informatics. Brown joins the company from Biovia, Dassault Systèmes (formerly Accelrys). He has also previously worked for Abbott Laboratories, Molecular Simulations, and Scitegic. 

Jan 05, 2015

Jason Moore

Jason Moore has been named the first permanent director of the Institute for Biomedical Informatics at University of Pennsylvania's Perelman School of Medicine. His appointment officially starts on March 1. 

Moore is the founding director of Dartmouth College's Institute for Quantitative Biomedical Sciences. He is currently a professor of genetics and of community and family medicine in Dartmouth's Geisel School of Medicine. Before joining the Dartmouth faculty, Moore was an associate professor of cancer research and a member of the Center for Human Genetics Research at Vanderbilt University. 

Jan 05, 2015

John Sninsky

CareDx has appointed John Sninsky as its new chief scientific officer. He most recently served as VP of discovery research at Celera, and following that firm's acquisition by Quest Diagnostics, he served as the head of Quest's Science & Innovation site in Alameda, Calif., and oversaw organization-wide bioinformatics.

Jan 05, 2015

Andrew Miller

Cepheid announced that CFO Andrew Miller will leave the firm on Feb. 3 to become CFO at PTC, a Needham, Mass.-based software firm. Cepheid VP and Corporate Controller Daniel Madden will assume the role of principal financial and accounting officer until a new CFO is appointed.

Dec 31, 2014

Andrew Olson

Tute Genomics has tapped Andrew Olson to serve as its vice president of sales. Prior to joining the company, Olson was VP of sales at Great Basin Corporation, a Utah-based healthcare technology firm. He's also worked as VP of sales and marketing at Signature Genomics.

Dec 30, 2014

Richard Schumacher

Richard Schumacher was reelected as a director of Pressure BioSciences. He will serve as a Class III director until the company's 2017 annual shareholders' meeting. Schumacher is the founder of Pressure Bio and is its president and CEO.

Dec 30, 2014

Cary Anne Simpson

Cary Anne Simpson has been named the new director of North American sales for VUV Analytics, a gas chromatography instrument manufacturer based in Austin, Texas. Simpson joins the firm from Thermo Fisher Scientific where she was most recently the national sales manager for the clinical controls product line. She also served Thermo Scientific as a North American sales manager of the Discrete Analyzer business as well as a regional sales manager in the Chromatography and Mass Spectrometry Division. Simpson also has worked in sales and sales management for Dionex and Polymer Laboratories.

Dec 30, 2014

Jeffrey Boschwitz, Theresa Zhang, Felix Dawson

Personal Genome Diagnostics named Jeffrey Boschwitz its chief operating officer, Theresa Zhang its VP of research services, and Felix Dawson to its board. Boschwitz was formerly executive VP of operations and corporate development at Plus Diagnostics. Prior to that, he was VP of North American sales and marketing at Orchid Cellmark and has held positions at Quest Diagnostics and Booz Allen Hamilton. 

Zhang joins PGDx from Merck Research Laboratories where she held various positions responsible for identification of predictive biomarkers and clinical implementation for oncology compounds. Dawson is a founding member of investment firm Wilkes Lane Capital. He previously was at Constellation Energy, now called Exelon, and at Goldman Sachs. 

Dec 22, 2014

John Gallagher

Becton Dickinson's board of directors has elected John Gallagher to the new position of vice president, corporate finance. Gallagher will replace Joseph Mercurio as BD's principal accounting officer, while remaining the firm's treasurer. Mercurio is moving to another undisclosed position within BD. 

Gallagher was most recently VP of business planning and analysis, and treasurer at BD. Prior to that, he was the company's VP and treasurer from 2012 to 2013. He was VP of financial planning and analysis at NBC Universal before joining BD.

Dec 22, 2014

Hamutal Anavi Russo

Hamutal Anavi Russo has joined Linkage Biosciences as chief financial officer. She has more than 15 years of financial management experience with medical devices and enterprise sofware firms and previously was CFO of OrSense.  

Dec 22, 2014

David Reiter

Luminex said that Senior VP, General Counsel, and Corporate Secretary David Reiter is resigning from the firm, effective on or around April 1, 2015. The firm said he resigned to pursue other interests and his departure is not the result of any disagreement with the company. Reiter will rejoin his independent legal practice, but he will serve as a consultant to Luminex from the time of his resignation until the end of 2015.

Dec 22, 2014

Bernard Tobin

Myriad Genetics has appointed Bernard Tobin as president of Crescendo Bioscience. Tobin joins Myriad from Amgen, where over the past seven years he has held various leadership roles, including executive director of national accounts, general manager of theNetherlandsandBrazil, as well as global head of commercial excellence. Before Amgen, Tobin had worked at Eli Lilly and Co.

Tobin will take over for William Hagstrom and report to Myriad CEO Peter Meldrum. Hagstrom has decided to leave Crescendo to pursue startup and social venture opportunities. He will stay with the company until Jan. 2, 2015, and Tobin's appointment will be effective as of Jan. 5.

Dec 19, 2014

Laurence Reid

Alnylam Pharmaceuticals said today that Chief Business Officer Laurence Reid will resign from the company at the end of 2014. Reid will be joining venture capital firm Third Rock Ventures as an entrepreneur-in-residence. He is expected to become CEO of a Third Rock Ventures-funded company in the future. Reid joined Alnylam in 2010.


Researchers test gene therapy targeting a different cancer protein in a new trial, the New York Times reports.

Pennsylvania State University researchers found that salivary microRNAs could predict which kids would have longer concussion symptoms, according to NPR.

The Associated Press reports Alex Azar, the new Department of Health and Human Services secretary nominee, made millions of dollars as a pharmaceutical executive.

In PNAS this week: immune profiling of breast cancer, transposable element patterns in rice, and more.